Form 4: Aethlon Medical Director Forfeits Shares for Tax

Aethlon Medical Director Edward G. Broenniman forfeited 893 common shares to cover tax withholdings related to restricted stock unit conversion.

Summary

• Edward G. Broenniman, a Director at Aethlon Medical Inc. (AEMD), reported a change in beneficial ownership.
• The transaction involved the forfeiture of 893 shares of common stock on September 30, 2025.
• This forfeiture occurred upon the conversion of an aggregate of 4,465 vested and outstanding restricted stock units into common stock.
• The shares were forfeited to cover tax withholdings, utilizing the market price of $0.749 per share at the time of forfeiture.
• Following this transaction, Edward G. Broenniman beneficially owns 25,397 shares of Aethlon Medical Inc. common stock directly.
• The restricted stock units were part of a grant previously reported in a Form 4 filed on April 25, 2025.

Sentiment

Score: 5

Explanation: The transaction is a neutral, non-discretionary event related to tax obligations from equity compensation, not indicative of positive or negative sentiment towards the company's prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for publicly traded companies with equity compensation plans. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in the director's investment thesis or company fundamentals.
• Employees: No direct impact on the broader employee base, as this relates to a specific director's equity compensation.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary transaction where a director forfeited shares to cover tax withholdings upon the vesting of restricted stock units. Such transactions are common for equity compensation and do not reflect a discretionary sale or purchase based on the director's view of the company's future performance. Therefore, this filing alone provides no new fundamental information to warrant a change from a 'hold' recommendation.

Keywords

AEMD, Aethlon Medical, Form 4, Insider Transaction, Stock Forfeiture, Restricted Stock Units, Director Compensation, Tax Withholding